-
Connolly leads Australia to four-wicket win over Bangladesh in T20 opener
-
England's Fisher and Archer strike against New Zealand after Stokes saga
-
Football, smoking and 'the boss': a G7 full of quirks
-
Spain logs third-warmest year on record in 2025
-
Queensland force State of Origin decider after rampant win
-
'Heartbreaking': Afghan govt staff abandon smartphones
-
Gill, Kishan tons power India to 402 in Afghanistan ODI
-
Groundbreaking US astronaut Christina Koch wins top Spanish award
-
BBC eyes compulsory redundancies in cost-cutting drive
-
Trump threatens 'dropping bombs' if Iran doesn't 'behave'
-
Oil steadies, stocks rise as US-Iran peace talks approach
-
Global data declaration targets illegal fishing
-
US not 'pulling away' from allies by cutting NATO commitments: Rutte
-
'I'm the boss', Trump tells G7 counterparts
-
Adidas runs out of letter 'V' as German fans snap up World Cup shirts
-
Van Aert out of Tour de France with elbow injury
-
Bernardo Silva signs two-year deal with Real Madrid
-
Louvre museum 'running out of steam', says new director
-
German grid connection deal to boost North Sea wind power
-
G7 leaders applaud Iran, Ukraine progress ahead of tackling AI
-
England enter World Cup fray as Ronaldo makes history
-
US military footprint growing in Australia: defence minister
-
France braces for heatwave with canal swimming allowed in Paris
-
Japan puts the heat on suspected ice cream cartel
-
Sovereignty fears to dog AI enthusiasm at France's Vivatech
-
MEXC May Report: SPACEX Launchpad Oversubscribed 15.5x, US Equity Futures Volume Jumps 85%
-
MEXC Prediction Markets Launches Combo to Enable Multi-Event Combination Trading
-
'We have always won': Ebola pioneer still on front line at 84
-
Australian far-right leader slams media, 'radical Islam' in testy press briefing
-
Stuffed toys and surfboards: Japan used goods market booms overseas
-
Messi salutes 'beautiful moment' after tying World Cup goals record
-
Putin hosts ASEAN leaders amid G7 pressure on Ukraine war
-
Iranian tankers exit US blockade zone ahead of peace talks
-
'Unstable' Tasmanian devil found after 15 days on the run
-
Magical Messi equals World Cup goals record as Argentina win
-
Messi equals World Cup goalscoring record in Argentina romp
-
Restore Britain, the hard-right party troubling Nigel Farage
-
Trap, neuter, release: Jakarta battles cat-astrophic stray numbers
-
Cuba's historic homes teeter on brink as economy collapses
-
EU lawmakers to approve migrant detention and deportation boost
-
Ronaldo as excited for sixth World Cup as his first, says Martinez
-
Macron winds up G7 with AI, Trump dinner
-
Norway coach hails Haaland after World Cup double
-
US Fed set to hold rates steady at Warsh's first meeting in charge
-
Argentina's Messi plays in record sixth World Cup
-
Kane tells England 'be free in the mind' for World Cup title bid
-
France and two-goal Mbappe roar into World Cup as Messi prepares
-
Trump ballroom cost soars to $600 mn, half from taxpayers: report
-
Swamp Thing: Algae mess with Trump's pool project
-
Haaland double powers Norway to World Cup win over Iraq
Who should get paid for nature's sequenced genes?
Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.
The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.
Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.
"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.
"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.
Much of the information comes from poor countries.
Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.
At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).
Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?
- 'Cheap and very fast' -
The issue is a complex one.
There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.
But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?
"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.
These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.
DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.
"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.
"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.
- Mandatory -
A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.
They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.
"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.
Another sticking point is access for Indigenous people and local communities to DSI funds.
Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.
But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.
With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.
The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.
Added Barber: "I think it's not going to all get solved here."
B.Khalifa--SF-PST